BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 6338440)

  • 21. Two methods of demonstrating leprosy bacilli in smears.
    Harada K; Kasai T
    Int J Lepr Other Mycobact Dis; 1978; 46(2):167. PubMed ID: 79561
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Borderline tuberculoid leprosy with a 'lepromatous' nodule of the nasal mucosa: a case report.
    Barton RP; Hogerzeil LM; McDougall AC
    Lepr India; 1980 Jan; 52(1):114-8. PubMed ID: 6991811
    [No Abstract]   [Full Text] [Related]  

  • 23. Borderline tuberculoid leprosy in childhood onset systemic lupus erythematosus patient.
    Lopes VA; Lourenço DM; Guariento A; Trindade MA; Avancini J; Silva CA
    Lupus; 2015 Nov; 24(13):1448-51. PubMed ID: 26113359
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vivo responses to Mycobacterium leprae: antigen presentation, interleukin-2 production, and immune cell phenotypes in naturally occurring leprosy lesions.
    Longley J; Haregewoin A; Yemaneberhan T; Warndorff van Diepen T; Nsibami J; Knowles D; Smith KA; Godal T
    Int J Lepr Other Mycobact Dis; 1985 Sep; 53(3):385-94. PubMed ID: 3900245
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oral lesions in leprosy.
    Costa A; Nery J; Oliveira M; Cuzzi T; Silva M
    Indian J Dermatol Venereol Leprol; 2003; 69(6):381-5. PubMed ID: 17642946
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Serological and cellular reactivity to mycobacterial proteins in Hansen's disease].
    Rada E; Aranzazu N; Rodríguez V; Borges R; Convit J
    Invest Clin; 2010 Sep; 51(3):325-40. PubMed ID: 21305770
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunology of leprosy.
    Britton WJ
    Trans R Soc Trop Med Hyg; 1993; 87(5):508-14. PubMed ID: 8266398
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Histologic responses in sixty multibacillary leprosy patients inoculated with autoclaved Mycobacterium leprae and live BCG.
    Meyers WM; McDougall AC; Fleury RN; Neves R; Reyes O; Binford CH
    Int J Lepr Other Mycobact Dis; 1988 Jun; 56(2):302-9. PubMed ID: 3045226
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Leprosy-specific oral lesions: a report of three cases.
    Motta AC; Komesu MC; Silva CH; Arruda D; Simão JC; Zenha EM; Furini RB; Foss NT
    Med Oral Patol Oral Cir Bucal; 2008 Aug; 13(8):E479-82. PubMed ID: 18667979
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oro-facial manifestations of 100 leprosy patients.
    Taheri JB; Mortazavi H; Moshfeghi M; Bakhshi M; Bakhtiari S; Azari-Marhabi S; Alirezaei S
    Med Oral Patol Oral Cir Bucal; 2012 Sep; 17(5):e728-32. PubMed ID: 22322502
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Severe type 1 upgrading leprosy reaction in a renal transplant recipient: a paradoxical manifestation associated with deficiency of antigen-specific regulatory T-cells?
    Vieira AP; Trindade MAB; de Paula FJ; Sakai-Valente NY; Duarte AJDS; Lemos FBC; Benard G
    BMC Infect Dis; 2017 Apr; 17(1):305. PubMed ID: 28438129
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Systemic involvement in tuberculoid leprosy--pathogenesis of leprosy.
    Singh R; Koranne RV
    Lepr India; 1979 Oct; 51(4):451-8. PubMed ID: 392191
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Diagnosis and treatment of leprous neuropathy in practice].
    Flageul B
    Rev Neurol (Paris); 2012 Dec; 168(12):960-6. PubMed ID: 23131313
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lichen scrofulosorum caused by Mycobacterium leprae: first report.
    Fiallo P; Cabiddu F; Clapasson A; Parodi A
    Int J Dermatol; 2014 Oct; 53(10):1244-8. PubMed ID: 25041689
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The histopathology of lepromatous leprosy in the nose.
    McDougall AC; Rees RJ; Weddell AG; Kanan MW
    J Pathol; 1975 Apr; 115(4):215-26. PubMed ID: 1099180
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Why relapse occurs in PB leprosy patients after adequate MDT despite they are Mitsuda reactive: lessons form Convit's experiment on bacteria-clearing capacity of lepromin-induced granuloma.
    Chaudhuri S; Hajra SK; Mukherjee A; Saha B; Mazumder B; Chattapadhya D; Saha K
    Int J Lepr Other Mycobact Dis; 1998 Jun; 66(2):182-9. PubMed ID: 9728450
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Simultaneous analysis of multiple T helper subsets in leprosy reveals distinct patterns of Th1, Th2, Th17 and Tregs markers expression in clinical forms and reactional events.
    Azevedo MCS; Marques H; Binelli LS; Malange MSV; Devides AC; Silva EA; Fachin LRV; Ghidella CC; Soares CT; Garlet GP; Rosa PS; Belone AFF; Trombone APF
    Med Microbiol Immunol; 2017 Dec; 206(6):429-439. PubMed ID: 28875310
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bacillaemia and Mycobacterium leprae cell wall antigen in paucibacillary leprosy.
    Kaur I; Kaur S; Sharma VK; Agnihotri N; Vaishnavi C; Ganguly NK
    Indian J Lepr; 1993; 65(3):283-8. PubMed ID: 8283063
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tumour necrosis factor-alpha (TNF-alpha) synthesis is associated with the skin and peripheral nerve pathology of leprosy reversal reactions.
    Khanolkar-Young S; Rayment N; Brickell PM; Katz DR; Vinayakumar S; Colston MJ; Lockwood DN
    Clin Exp Immunol; 1995 Feb; 99(2):196-202. PubMed ID: 7851011
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Presence of oral lesions in leprosy patients does not imply involvement by Mycobacterium leprae.
    Morgado de Abreu MA; Neto Pimentel DR; Morgado de Abreu NM; Watashi Hirata CH; Michalany NS; Maurice Weckx LL; Mota de Avelar Alchorne M
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Mar; 109(3):328-9. PubMed ID: 20056461
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.